rs4652673
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001205293.3(CACNA1E):c.1056-14921G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.685 in 151,916 control chromosomes in the GnomAD database, including 35,741 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.68 ( 35741 hom., cov: 32)
Consequence
CACNA1E
NM_001205293.3 intron
NM_001205293.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.107
Publications
2 publications found
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.768 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1E | NM_001205293.3 | c.1056-14921G>A | intron_variant | Intron 7 of 47 | ENST00000367573.7 | NP_001192222.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | ENST00000367573.7 | c.1056-14921G>A | intron_variant | Intron 7 of 47 | 1 | NM_001205293.3 | ENSP00000356545.2 | |||
| CACNA1E | ENST00000360108.7 | c.1056-14921G>A | intron_variant | Intron 7 of 46 | 5 | ENSP00000353222.3 | ||||
| CACNA1E | ENST00000367570.6 | c.1056-14921G>A | intron_variant | Intron 7 of 46 | 1 | ENSP00000356542.1 | ||||
| CACNA1E | ENST00000621791.4 | c.1056-14921G>A | intron_variant | Intron 7 of 45 | 1 | ENSP00000481619.1 | ||||
| CACNA1E | ENST00000524607.6 | c.1491-14921G>A | intron_variant | Intron 9 of 11 | 5 | ENSP00000432038.2 |
Frequencies
GnomAD3 genomes AF: 0.685 AC: 103938AN: 151798Hom.: 35713 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
103938
AN:
151798
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.685 AC: 104010AN: 151916Hom.: 35741 Cov.: 32 AF XY: 0.688 AC XY: 51075AN XY: 74262 show subpopulations
GnomAD4 genome
AF:
AC:
104010
AN:
151916
Hom.:
Cov.:
32
AF XY:
AC XY:
51075
AN XY:
74262
show subpopulations
African (AFR)
AF:
AC:
26360
AN:
41396
American (AMR)
AF:
AC:
9570
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
2534
AN:
3470
East Asian (EAS)
AF:
AC:
4079
AN:
5176
South Asian (SAS)
AF:
AC:
3151
AN:
4812
European-Finnish (FIN)
AF:
AC:
7576
AN:
10570
Middle Eastern (MID)
AF:
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48428
AN:
67918
Other (OTH)
AF:
AC:
1372
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1680
3359
5039
6718
8398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2315
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.